BusinessSpotlight Innovation Subsidiary Celtic Biotech Iowa Announces Results from Two Cohorts of Phase I Trial of Crotoxin for the Treatment of CancerBy Nasdaq OMXApr 18, 2018, 12:48 PM UTC